Additionally, Western blot analysis of tumor tissue indicated that 50 mg/kg cyclobrachycoumarin decreased the expressions of CDK1, total PARP, and survivin while enhancing cleaved PARP levels in vivo (Figure 5g,h). Here, BIRC5 is linked to neoplasm.